Illumina Body Map 2
Name | miRBASE accession |
---|---|
hsa-miR-128-3p
|
MIMAT0000424 |
hsa-miR-216a-3p
|
MIMAT0022844 |
hsa-miR-3681-3p
|
MIMAT0018109 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_34642656 | 2.96 |
ENST00000257831.3
ENST00000450654.2 |
EHF
|
ets homologous factor |
chr14_-_30396948 | 2.53 |
ENST00000331968.5
|
PRKD1
|
protein kinase D1 |
chrX_+_105066524 | 2.49 |
ENST00000243300.9
ENST00000428173.2 |
NRK
|
Nik related kinase |
chr6_+_41606176 | 2.16 |
ENST00000441667.1
ENST00000230321.6 ENST00000373050.4 ENST00000446650.1 ENST00000435476.1 |
MDFI
|
MyoD family inhibitor |
chr4_+_55095264 | 1.95 |
ENST00000257290.5
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide |
chr1_-_205326022 | 1.90 |
ENST00000367155.3
|
KLHDC8A
|
kelch domain containing 8A |
chr7_-_27183263 | 1.90 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
chr15_+_96873921 | 1.89 |
ENST00000394166.3
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr16_-_65155833 | 1.86 |
ENST00000566827.1
ENST00000394156.3 ENST00000562998.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
chr3_+_139654018 | 1.83 |
ENST00000458420.3
|
CLSTN2
|
calsyntenin 2 |
chr12_-_88974236 | 1.79 |
ENST00000228280.5
ENST00000552044.1 ENST00000357116.4 |
KITLG
|
KIT ligand |
chr17_-_46692287 | 1.78 |
ENST00000239144.4
|
HOXB8
|
homeobox B8 |
chr5_-_38595498 | 1.78 |
ENST00000263409.4
|
LIFR
|
leukemia inhibitory factor receptor alpha |
chr1_-_68299130 | 1.75 |
ENST00000370982.3
|
GNG12
|
guanine nucleotide binding protein (G protein), gamma 12 |
chr1_-_57045228 | 1.73 |
ENST00000371250.3
|
PPAP2B
|
phosphatidic acid phosphatase type 2B |
chr8_+_134203273 | 1.71 |
ENST00000250160.6
|
WISP1
|
WNT1 inducible signaling pathway protein 1 |
chr14_+_100259666 | 1.68 |
ENST00000262233.6
ENST00000334192.4 |
EML1
|
echinoderm microtubule associated protein like 1 |
chr20_+_10199468 | 1.68 |
ENST00000254976.2
ENST00000304886.2 |
SNAP25
|
synaptosomal-associated protein, 25kDa |
chr19_+_15218180 | 1.66 |
ENST00000342784.2
ENST00000597977.1 ENST00000600440.1 |
SYDE1
|
synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
chr17_+_12569306 | 1.64 |
ENST00000425538.1
|
MYOCD
|
myocardin |
chr9_+_132934835 | 1.63 |
ENST00000372398.3
|
NCS1
|
neuronal calcium sensor 1 |
chr4_+_20255123 | 1.59 |
ENST00000504154.1
ENST00000273739.5 |
SLIT2
|
slit homolog 2 (Drosophila) |
chr5_+_172068232 | 1.58 |
ENST00000520919.1
ENST00000522853.1 ENST00000369800.5 |
NEURL1B
|
neuralized E3 ubiquitin protein ligase 1B |
chr6_-_166075557 | 1.55 |
ENST00000539869.2
ENST00000366882.1 |
PDE10A
|
phosphodiesterase 10A |
chr17_+_47572647 | 1.54 |
ENST00000172229.3
|
NGFR
|
nerve growth factor receptor |
chr6_+_127439749 | 1.54 |
ENST00000356698.4
|
RSPO3
|
R-spondin 3 |
chr12_+_54422142 | 1.53 |
ENST00000243108.4
|
HOXC6
|
homeobox C6 |
chr9_+_116917807 | 1.45 |
ENST00000356083.3
|
COL27A1
|
collagen, type XXVII, alpha 1 |
chr2_-_27718052 | 1.45 |
ENST00000264703.3
|
FNDC4
|
fibronectin type III domain containing 4 |
chr7_-_27239703 | 1.44 |
ENST00000222753.4
|
HOXA13
|
homeobox A13 |
chr1_+_160370344 | 1.42 |
ENST00000368061.2
|
VANGL2
|
VANGL planar cell polarity protein 2 |
chr11_+_12695944 | 1.41 |
ENST00000361905.4
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
chr1_+_117452669 | 1.37 |
ENST00000393203.2
|
PTGFRN
|
prostaglandin F2 receptor inhibitor |
chr4_+_85504075 | 1.35 |
ENST00000295887.5
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 |
chr15_+_41221536 | 1.35 |
ENST00000249749.5
|
DLL4
|
delta-like 4 (Drosophila) |
chr18_+_19749386 | 1.35 |
ENST00000269216.3
|
GATA6
|
GATA binding protein 6 |
chr15_+_33010175 | 1.34 |
ENST00000300177.4
ENST00000560677.1 ENST00000560830.1 |
GREM1
|
gremlin 1, DAN family BMP antagonist |
chr5_-_121413974 | 1.33 |
ENST00000231004.4
|
LOX
|
lysyl oxidase |
chr8_+_40010989 | 1.30 |
ENST00000315792.3
|
C8orf4
|
chromosome 8 open reading frame 4 |
chr22_+_41956767 | 1.27 |
ENST00000306149.7
|
CSDC2
|
cold shock domain containing C2, RNA binding |
chr15_-_37390482 | 1.27 |
ENST00000559085.1
ENST00000397624.3 |
MEIS2
|
Meis homeobox 2 |
chr15_-_63674218 | 1.26 |
ENST00000178638.3
|
CA12
|
carbonic anhydrase XII |
chr1_+_65613217 | 1.25 |
ENST00000545314.1
|
AK4
|
adenylate kinase 4 |
chr14_+_37667118 | 1.24 |
ENST00000556615.1
ENST00000327441.7 ENST00000536774.1 |
MIPOL1
|
mirror-image polydactyly 1 |
chr8_-_81787006 | 1.23 |
ENST00000327835.3
|
ZNF704
|
zinc finger protein 704 |
chr6_+_1312675 | 1.22 |
ENST00000296839.2
|
FOXQ1
|
forkhead box Q1 |
chr7_-_103629963 | 1.22 |
ENST00000428762.1
ENST00000343529.5 ENST00000424685.2 |
RELN
|
reelin |
chr20_+_34700333 | 1.18 |
ENST00000441639.1
|
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chr17_-_8534067 | 1.16 |
ENST00000360416.3
ENST00000269243.4 |
MYH10
|
myosin, heavy chain 10, non-muscle |
chr1_-_95392635 | 1.16 |
ENST00000538964.1
ENST00000394202.4 ENST00000370206.4 |
CNN3
|
calponin 3, acidic |
chr5_-_57756087 | 1.14 |
ENST00000274289.3
|
PLK2
|
polo-like kinase 2 |
chr10_-_131762105 | 1.14 |
ENST00000368648.3
ENST00000355311.5 |
EBF3
|
early B-cell factor 3 |
chr8_+_76452097 | 1.13 |
ENST00000396423.2
|
HNF4G
|
hepatocyte nuclear factor 4, gamma |
chr17_+_72983674 | 1.12 |
ENST00000337231.5
|
CDR2L
|
cerebellar degeneration-related protein 2-like |
chr5_-_179780312 | 1.11 |
ENST00000253778.8
|
GFPT2
|
glutamine-fructose-6-phosphate transaminase 2 |
chr3_-_164913777 | 1.10 |
ENST00000475390.1
|
SLITRK3
|
SLIT and NTRK-like family, member 3 |
chr1_-_86043921 | 1.10 |
ENST00000535924.2
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1 |
chr6_-_119399895 | 1.09 |
ENST00000338891.7
|
FAM184A
|
family with sequence similarity 184, member A |
chr4_+_113970772 | 1.07 |
ENST00000504454.1
ENST00000394537.3 ENST00000357077.4 ENST00000264366.6 |
ANK2
|
ankyrin 2, neuronal |
chr12_-_77272765 | 1.07 |
ENST00000547435.1
ENST00000552330.1 ENST00000546966.1 ENST00000311083.5 |
CSRP2
|
cysteine and glycine-rich protein 2 |
chr5_-_160279207 | 1.07 |
ENST00000327245.5
|
ATP10B
|
ATPase, class V, type 10B |
chr1_-_51763661 | 1.07 |
ENST00000530004.1
|
TTC39A
|
tetratricopeptide repeat domain 39A |
chr17_+_11144580 | 1.06 |
ENST00000441885.3
ENST00000432116.3 ENST00000409168.3 |
SHISA6
|
shisa family member 6 |
chr2_+_43864387 | 1.04 |
ENST00000282406.4
|
PLEKHH2
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 2 |
chr17_+_8924837 | 1.03 |
ENST00000173229.2
|
NTN1
|
netrin 1 |
chr9_-_140196703 | 1.03 |
ENST00000356628.2
|
NRARP
|
NOTCH-regulated ankyrin repeat protein |
chr18_-_30050395 | 1.03 |
ENST00000269209.6
ENST00000399218.4 |
GAREM
|
GRB2 associated, regulator of MAPK1 |
chr5_-_115910630 | 1.03 |
ENST00000343348.6
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chr1_-_225840747 | 1.02 |
ENST00000366843.2
ENST00000366844.3 |
ENAH
|
enabled homolog (Drosophila) |
chr20_+_2673383 | 1.02 |
ENST00000380648.4
ENST00000342725.5 |
EBF4
|
early B-cell factor 4 |
chr8_-_41166953 | 1.02 |
ENST00000220772.3
|
SFRP1
|
secreted frizzled-related protein 1 |
chr4_-_177713788 | 1.00 |
ENST00000280193.2
|
VEGFC
|
vascular endothelial growth factor C |
chr16_+_77822427 | 0.98 |
ENST00000302536.2
|
VAT1L
|
vesicle amine transport 1-like |
chr4_-_174451370 | 0.98 |
ENST00000359562.4
|
HAND2
|
heart and neural crest derivatives expressed 2 |
chr13_-_107187462 | 0.98 |
ENST00000245323.4
|
EFNB2
|
ephrin-B2 |
chr1_-_117210290 | 0.98 |
ENST00000369483.1
ENST00000369486.3 |
IGSF3
|
immunoglobulin superfamily, member 3 |
chr5_+_132149017 | 0.97 |
ENST00000378693.2
|
SOWAHA
|
sosondowah ankyrin repeat domain family member A |
chr10_-_90712520 | 0.96 |
ENST00000224784.6
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
chr20_-_14318248 | 0.96 |
ENST00000378053.3
ENST00000341420.4 |
FLRT3
|
fibronectin leucine rich transmembrane protein 3 |
chr16_+_66400533 | 0.96 |
ENST00000341529.3
|
CDH5
|
cadherin 5, type 2 (vascular endothelium) |
chr9_+_124413873 | 0.93 |
ENST00000408936.3
|
DAB2IP
|
DAB2 interacting protein |
chr10_-_15762124 | 0.93 |
ENST00000378076.3
|
ITGA8
|
integrin, alpha 8 |
chr9_+_118916082 | 0.92 |
ENST00000328252.3
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1 |
chr9_-_14314066 | 0.90 |
ENST00000397575.3
|
NFIB
|
nuclear factor I/B |
chr16_-_70719925 | 0.89 |
ENST00000338779.6
|
MTSS1L
|
metastasis suppressor 1-like |
chr3_+_36421826 | 0.88 |
ENST00000273183.3
|
STAC
|
SH3 and cysteine rich domain |
chr4_+_81951957 | 0.87 |
ENST00000282701.2
|
BMP3
|
bone morphogenetic protein 3 |
chr7_+_94285637 | 0.87 |
ENST00000482108.1
ENST00000488574.1 |
PEG10
|
paternally expressed 10 |
chr17_-_50237343 | 0.87 |
ENST00000575181.1
ENST00000570565.1 |
CA10
|
carbonic anhydrase X |
chr8_-_97173020 | 0.86 |
ENST00000287020.5
|
GDF6
|
growth differentiation factor 6 |
chr12_-_120806960 | 0.85 |
ENST00000257552.2
|
MSI1
|
musashi RNA-binding protein 1 |
chr5_+_34656331 | 0.85 |
ENST00000265109.3
|
RAI14
|
retinoic acid induced 14 |
chr4_-_13546632 | 0.84 |
ENST00000382438.5
|
NKX3-2
|
NK3 homeobox 2 |
chrX_-_54384425 | 0.84 |
ENST00000375169.3
ENST00000354646.2 |
WNK3
|
WNK lysine deficient protein kinase 3 |
chr2_-_166651191 | 0.83 |
ENST00000392701.3
|
GALNT3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
chr2_-_50574856 | 0.82 |
ENST00000342183.5
|
NRXN1
|
neurexin 1 |
chr2_+_189839046 | 0.82 |
ENST00000304636.3
ENST00000317840.5 |
COL3A1
|
collagen, type III, alpha 1 |
chr11_-_45687128 | 0.82 |
ENST00000308064.2
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
chr4_-_111119804 | 0.80 |
ENST00000394607.3
ENST00000302274.3 |
ELOVL6
|
ELOVL fatty acid elongase 6 |
chr3_-_56502375 | 0.80 |
ENST00000288221.6
|
ERC2
|
ELKS/RAB6-interacting/CAST family member 2 |
chr4_+_115519577 | 0.80 |
ENST00000310836.6
|
UGT8
|
UDP glycosyltransferase 8 |
chr6_+_136172820 | 0.79 |
ENST00000308191.6
|
PDE7B
|
phosphodiesterase 7B |
chr13_-_103053946 | 0.78 |
ENST00000376131.4
|
FGF14
|
fibroblast growth factor 14 |
chr9_+_109625378 | 0.78 |
ENST00000277225.5
ENST00000457913.1 ENST00000472574.1 |
ZNF462
|
zinc finger protein 462 |
chr7_+_116312411 | 0.76 |
ENST00000456159.1
ENST00000397752.3 ENST00000318493.6 |
MET
|
met proto-oncogene |
chr12_-_105478339 | 0.75 |
ENST00000424857.2
ENST00000258494.9 |
ALDH1L2
|
aldehyde dehydrogenase 1 family, member L2 |
chr19_+_51815102 | 0.75 |
ENST00000270642.8
|
IGLON5
|
IgLON family member 5 |
chr16_+_66878814 | 0.75 |
ENST00000394069.3
|
CA7
|
carbonic anhydrase VII |
chr14_+_101193164 | 0.74 |
ENST00000341267.4
|
DLK1
|
delta-like 1 homolog (Drosophila) |
chr7_-_123673471 | 0.74 |
ENST00000455783.1
|
TMEM229A
|
transmembrane protein 229A |
chr5_+_50678921 | 0.72 |
ENST00000230658.7
|
ISL1
|
ISL LIM homeobox 1 |
chr1_+_110453203 | 0.72 |
ENST00000357302.4
ENST00000344188.5 ENST00000329608.6 |
CSF1
|
colony stimulating factor 1 (macrophage) |
chr4_-_107957454 | 0.71 |
ENST00000285311.3
|
DKK2
|
dickkopf WNT signaling pathway inhibitor 2 |
chr14_+_37131058 | 0.71 |
ENST00000361487.6
|
PAX9
|
paired box 9 |
chr12_+_79258547 | 0.68 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
chr17_+_32907768 | 0.68 |
ENST00000321639.5
|
TMEM132E
|
transmembrane protein 132E |
chr14_-_92413727 | 0.68 |
ENST00000267620.10
|
FBLN5
|
fibulin 5 |
chr21_-_39870339 | 0.66 |
ENST00000429727.2
ENST00000398905.1 ENST00000398907.1 ENST00000453032.2 ENST00000288319.7 |
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog |
chr3_-_24536253 | 0.65 |
ENST00000428492.1
ENST00000396671.2 ENST00000431815.1 ENST00000418247.1 ENST00000416420.1 ENST00000356447.4 |
THRB
|
thyroid hormone receptor, beta |
chr5_+_148960931 | 0.65 |
ENST00000333677.6
|
ARHGEF37
|
Rho guanine nucleotide exchange factor (GEF) 37 |
chr7_-_27213893 | 0.65 |
ENST00000283921.4
|
HOXA10
|
homeobox A10 |
chr8_-_91997427 | 0.64 |
ENST00000517562.2
|
RP11-122A3.2
|
chromosome 8 open reading frame 88 |
chr4_+_184826418 | 0.64 |
ENST00000308497.4
ENST00000438269.1 |
STOX2
|
storkhead box 2 |
chrX_+_102631248 | 0.64 |
ENST00000361298.4
ENST00000372645.3 ENST00000372635.1 |
NGFRAP1
|
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr2_+_158114051 | 0.63 |
ENST00000259056.4
|
GALNT5
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) |
chr1_+_199996702 | 0.63 |
ENST00000367362.3
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2 |
chr12_+_20522179 | 0.62 |
ENST00000359062.3
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited |
chr15_+_73344791 | 0.62 |
ENST00000261908.6
|
NEO1
|
neogenin 1 |
chrX_-_25034065 | 0.62 |
ENST00000379044.4
|
ARX
|
aristaless related homeobox |
chr9_+_103790991 | 0.61 |
ENST00000374874.3
|
LPPR1
|
Lipid phosphate phosphatase-related protein type 1 |
chr2_-_151344172 | 0.61 |
ENST00000375734.2
ENST00000263895.4 ENST00000454202.1 |
RND3
|
Rho family GTPase 3 |
chr3_+_11034403 | 0.59 |
ENST00000287766.4
ENST00000425938.1 |
SLC6A1
|
solute carrier family 6 (neurotransmitter transporter), member 1 |
chr6_-_88876058 | 0.58 |
ENST00000369501.2
|
CNR1
|
cannabinoid receptor 1 (brain) |
chr1_-_37499726 | 0.58 |
ENST00000373091.3
ENST00000373093.4 |
GRIK3
|
glutamate receptor, ionotropic, kainate 3 |
chr7_+_155250824 | 0.58 |
ENST00000297375.4
|
EN2
|
engrailed homeobox 2 |
chr17_+_56833184 | 0.58 |
ENST00000308249.2
|
PPM1E
|
protein phosphatase, Mg2+/Mn2+ dependent, 1E |
chr1_-_154474589 | 0.58 |
ENST00000304760.2
|
SHE
|
Src homology 2 domain containing E |
chr2_+_232260254 | 0.58 |
ENST00000287590.5
|
B3GNT7
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 |
chr2_+_206547215 | 0.58 |
ENST00000360409.3
ENST00000540178.1 ENST00000540841.1 ENST00000355117.4 ENST00000450507.1 ENST00000417189.1 |
NRP2
|
neuropilin 2 |
chr17_+_35294075 | 0.57 |
ENST00000254457.5
|
LHX1
|
LIM homeobox 1 |
chr8_+_28351707 | 0.57 |
ENST00000537916.1
ENST00000523546.1 ENST00000240093.3 |
FZD3
|
frizzled family receptor 3 |
chr3_-_170303845 | 0.55 |
ENST00000231706.5
|
SLC7A14
|
solute carrier family 7, member 14 |
chr12_-_71031220 | 0.55 |
ENST00000334414.6
|
PTPRB
|
protein tyrosine phosphatase, receptor type, B |
chr5_+_42423872 | 0.54 |
ENST00000230882.4
ENST00000357703.3 |
GHR
|
growth hormone receptor |
chr6_+_118228657 | 0.54 |
ENST00000360388.4
|
SLC35F1
|
solute carrier family 35, member F1 |
chr14_-_59932044 | 0.53 |
ENST00000395116.1
|
GPR135
|
G protein-coupled receptor 135 |
chr4_+_5053162 | 0.53 |
ENST00000282908.5
|
STK32B
|
serine/threonine kinase 32B |
chr20_+_24449821 | 0.53 |
ENST00000376862.3
|
SYNDIG1
|
synapse differentiation inducing 1 |
chr21_-_43346790 | 0.52 |
ENST00000329623.7
|
C2CD2
|
C2 calcium-dependent domain containing 2 |
chr17_-_78450398 | 0.51 |
ENST00000306773.4
|
NPTX1
|
neuronal pentraxin I |
chr1_+_215256467 | 0.51 |
ENST00000391894.2
ENST00000444842.2 |
KCNK2
|
potassium channel, subfamily K, member 2 |
chr14_-_27066636 | 0.51 |
ENST00000267422.7
ENST00000344429.5 ENST00000574031.1 ENST00000465357.2 ENST00000547619.1 |
NOVA1
|
neuro-oncological ventral antigen 1 |
chr19_-_2721412 | 0.51 |
ENST00000323469.4
|
DIRAS1
|
DIRAS family, GTP-binding RAS-like 1 |
chr5_+_76506706 | 0.51 |
ENST00000340978.3
ENST00000346042.3 ENST00000264917.5 ENST00000342343.4 ENST00000333194.4 |
PDE8B
|
phosphodiesterase 8B |
chr3_-_32022733 | 0.51 |
ENST00000438237.2
ENST00000396556.2 |
OSBPL10
|
oxysterol binding protein-like 10 |
chr7_+_100210133 | 0.51 |
ENST00000393950.2
ENST00000424091.2 |
MOSPD3
|
motile sperm domain containing 3 |
chr1_-_161059380 | 0.50 |
ENST00000368012.3
|
PVRL4
|
poliovirus receptor-related 4 |
chr17_+_1958388 | 0.50 |
ENST00000399849.3
|
HIC1
|
hypermethylated in cancer 1 |
chr10_+_60272814 | 0.49 |
ENST00000373886.3
|
BICC1
|
bicaudal C homolog 1 (Drosophila) |
chr2_+_210636697 | 0.49 |
ENST00000439458.1
ENST00000272845.6 |
UNC80
|
unc-80 homolog (C. elegans) |
chr12_+_103981044 | 0.49 |
ENST00000388887.2
|
STAB2
|
stabilin 2 |
chr3_-_116164306 | 0.48 |
ENST00000490035.2
|
LSAMP
|
limbic system-associated membrane protein |
chr6_-_46293378 | 0.48 |
ENST00000330430.6
|
RCAN2
|
regulator of calcineurin 2 |
chr1_+_61547894 | 0.47 |
ENST00000403491.3
|
NFIA
|
nuclear factor I/A |
chr20_-_41818373 | 0.47 |
ENST00000373187.1
ENST00000356100.2 ENST00000373184.1 ENST00000373190.1 |
PTPRT
|
protein tyrosine phosphatase, receptor type, T |
chr17_-_41977964 | 0.47 |
ENST00000377184.3
|
MPP2
|
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) |
chr14_+_33408449 | 0.46 |
ENST00000346562.2
ENST00000341321.4 ENST00000548645.1 ENST00000356141.4 ENST00000357798.5 |
NPAS3
|
neuronal PAS domain protein 3 |
chr2_-_9143786 | 0.46 |
ENST00000462696.1
ENST00000305997.3 |
MBOAT2
|
membrane bound O-acyltransferase domain containing 2 |
chr1_+_205012293 | 0.46 |
ENST00000331830.4
|
CNTN2
|
contactin 2 (axonal) |
chr12_-_12419703 | 0.46 |
ENST00000543091.1
ENST00000261349.4 |
LRP6
|
low density lipoprotein receptor-related protein 6 |
chr10_-_81205373 | 0.46 |
ENST00000372336.3
|
ZCCHC24
|
zinc finger, CCHC domain containing 24 |
chr10_-_21786179 | 0.45 |
ENST00000377113.5
|
CASC10
|
cancer susceptibility candidate 10 |
chr16_+_1756162 | 0.45 |
ENST00000250894.4
ENST00000356010.5 |
MAPK8IP3
|
mitogen-activated protein kinase 8 interacting protein 3 |
chr12_+_110152033 | 0.45 |
ENST00000538780.1
|
FAM222A
|
family with sequence similarity 222, member A |
chrX_+_17393543 | 0.45 |
ENST00000380060.3
|
NHS
|
Nance-Horan syndrome (congenital cataracts and dental anomalies) |
chr1_-_99470558 | 0.45 |
ENST00000370188.3
|
LPPR5
|
Lipid phosphate phosphatase-related protein type 5 |
chr9_+_116638562 | 0.44 |
ENST00000374126.5
ENST00000288466.7 |
ZNF618
|
zinc finger protein 618 |
chr9_-_93405352 | 0.44 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
chr14_-_100070363 | 0.44 |
ENST00000380243.4
|
CCDC85C
|
coiled-coil domain containing 85C |
chr21_+_35445827 | 0.43 |
ENST00000608209.1
ENST00000381151.3 |
SLC5A3
SLC5A3
|
sodium/myo-inositol cotransporter solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
chr2_-_164592497 | 0.43 |
ENST00000333129.3
ENST00000409634.1 |
FIGN
|
fidgetin |
chr12_-_82153087 | 0.43 |
ENST00000547623.1
ENST00000549396.1 |
PPFIA2
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
chr5_-_93447333 | 0.43 |
ENST00000395965.3
ENST00000505869.1 ENST00000509163.1 |
FAM172A
|
family with sequence similarity 172, member A |
chr3_-_87040233 | 0.42 |
ENST00000398399.2
|
VGLL3
|
vestigial like 3 (Drosophila) |
chr2_-_25142708 | 0.42 |
ENST00000260600.5
ENST00000435135.1 |
ADCY3
|
adenylate cyclase 3 |
chr6_+_142622991 | 0.42 |
ENST00000230173.6
ENST00000367608.2 |
GPR126
|
G protein-coupled receptor 126 |
chr19_-_14629224 | 0.42 |
ENST00000254322.2
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
chr13_-_108518986 | 0.42 |
ENST00000375915.2
|
FAM155A
|
family with sequence similarity 155, member A |
chr6_-_99873145 | 0.42 |
ENST00000369239.5
ENST00000438806.1 |
PNISR
|
PNN-interacting serine/arginine-rich protein |
chr5_+_52285144 | 0.41 |
ENST00000296585.5
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
chr16_-_68482440 | 0.41 |
ENST00000219334.5
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) |
chr21_+_33245548 | 0.40 |
ENST00000270112.2
|
HUNK
|
hormonally up-regulated Neu-associated kinase |
chr20_+_20348740 | 0.40 |
ENST00000310227.1
|
INSM1
|
insulinoma-associated 1 |
chr1_-_95007193 | 0.40 |
ENST00000370207.4
ENST00000334047.7 |
F3
|
coagulation factor III (thromboplastin, tissue factor) |
chr12_-_109747023 | 0.39 |
ENST00000355216.1
ENST00000299162.5 |
FOXN4
|
forkhead box N4 |
chr12_+_70760056 | 0.39 |
ENST00000258111.4
|
KCNMB4
|
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
chr9_-_23821273 | 0.38 |
ENST00000380110.4
|
ELAVL2
|
ELAV like neuron-specific RNA binding protein 2 |
chr6_-_99797522 | 0.38 |
ENST00000389677.5
|
FAXC
|
failed axon connections homolog (Drosophila) |
chr18_-_31803435 | 0.38 |
ENST00000589544.1
ENST00000269185.4 ENST00000261592.5 |
NOL4
|
nucleolar protein 4 |
chr1_+_116184566 | 0.38 |
ENST00000355485.2
ENST00000369510.4 |
VANGL1
|
VANGL planar cell polarity protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0060435 | bronchiole development(GO:0060435) |
0.6 | 2.5 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.6 | 1.8 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.5 | 1.6 | GO:1902623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.5 | 2.6 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 2.9 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.5 | 1.4 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.5 | 1.9 | GO:0009956 | radial pattern formation(GO:0009956) |
0.4 | 1.3 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
0.4 | 1.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.4 | 1.3 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.4 | 1.7 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.4 | 1.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.4 | 1.5 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.3 | 0.6 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.3 | 2.5 | GO:1901727 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) protein kinase D signaling(GO:0089700) positive regulation of histone deacetylase activity(GO:1901727) |
0.3 | 2.0 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.3 | 1.6 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 1.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.7 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.2 | 1.1 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
0.2 | 1.5 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.2 | 1.4 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 0.9 | GO:0043553 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 1.0 | GO:1901490 | positive regulation of mast cell chemotaxis(GO:0060754) regulation of lymphangiogenesis(GO:1901490) |
0.2 | 1.0 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.2 | 1.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.8 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.1 | 0.7 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.1 | 0.6 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 1.2 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.1 | 0.7 | GO:0060611 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.1 | 2.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 1.3 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.4 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.1 | 0.4 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 0.7 | GO:0008050 | female courtship behavior(GO:0008050) |
0.1 | 1.3 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 2.3 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.6 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 1.2 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 1.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.4 | GO:0008306 | associative learning(GO:0008306) |
0.1 | 0.6 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.1 | 0.5 | GO:0031133 | regulation of axon diameter(GO:0031133) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.1 | 0.7 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.1 | 0.9 | GO:2000791 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.1 | 1.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.8 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.4 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.1 | 0.9 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.1 | 0.6 | GO:0001893 | maternal placenta development(GO:0001893) |
0.1 | 0.4 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.6 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 1.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.5 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.1 | 1.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.7 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 1.4 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.8 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.1 | 0.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.2 | GO:0060458 | right lung development(GO:0060458) primary prostatic bud elongation(GO:0060516) |
0.1 | 0.6 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
0.1 | 0.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.1 | 0.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 1.0 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 1.0 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 1.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.3 | GO:0072240 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
0.1 | 0.3 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.1 | 1.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.1 | 0.5 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.1 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.2 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 1.0 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
0.1 | 0.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.3 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 0.8 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.1 | GO:0001743 | optic placode formation(GO:0001743) axial mesoderm formation(GO:0048320) |
0.1 | 0.8 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 1.8 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.2 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.1 | 0.5 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.6 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 1.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.1 | 0.2 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.1 | 0.1 | GO:0021767 | mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) |
0.1 | 1.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.2 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
0.0 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.8 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 | 0.6 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.1 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.0 | 0.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.0 | 0.2 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.0 | 0.7 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 1.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.6 | GO:0097490 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.0 | 0.1 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.0 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.4 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.0 | 1.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.2 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.0 | 0.3 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.4 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 2.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.3 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.0 | 0.1 | GO:0044691 | tooth eruption(GO:0044691) |
0.0 | 0.0 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
0.0 | 1.4 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.0 | 1.4 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.0 | 0.1 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.0 | 0.3 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 2.1 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.2 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.5 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.9 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.5 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 0.1 | GO:1904075 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.0 | 0.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.0 | 0.3 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.4 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.7 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.0 | 1.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 1.3 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.0 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.4 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.9 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.5 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.7 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.0 | 0.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.3 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.1 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.0 | 0.5 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.1 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.5 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.0 | 0.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 0.8 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.0 | 0.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.6 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.2 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.5 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.0 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.4 | GO:0060187 | cell pole(GO:0060187) |
0.3 | 0.9 | GO:1990032 | parallel fiber(GO:1990032) |
0.2 | 1.4 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.2 | 0.9 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.2 | 1.7 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.2 | 1.2 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 0.5 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.2 | 1.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 2.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.7 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 0.6 | GO:0042025 | host cell nucleus(GO:0042025) |
0.1 | 1.6 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.6 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 0.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 1.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 2.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 1.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.1 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.0 | 0.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.1 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.0 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 1.0 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.8 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.9 | GO:0043034 | costamere(GO:0043034) |
0.0 | 2.0 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 2.8 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.9 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 2.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 1.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 1.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 6.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.0 | GO:0005018 | platelet-derived growth factor alpha-receptor activity(GO:0005018) |
0.4 | 1.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 1.8 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.3 | 1.4 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.3 | 1.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 0.8 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.2 | 1.2 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.2 | 1.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 1.5 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.2 | 1.1 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.2 | 0.5 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
0.2 | 0.8 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.1 | 2.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.4 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
0.1 | 0.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 2.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.3 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.1 | 1.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 2.8 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.0 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 2.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 1.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.6 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 1.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 2.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 1.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 1.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.1 | 0.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.2 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.0 | 1.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.1 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.0 | 0.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.3 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.0 | 1.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 1.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 1.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 1.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 1.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 1.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 1.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.5 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.0 | 0.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.3 | GO:0098821 | inhibin binding(GO:0034711) BMP receptor activity(GO:0098821) |
0.0 | 0.9 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 1.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 1.2 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.2 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 1.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 11.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 1.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.8 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 1.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.0 | 0.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.4 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 2.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 2.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 1.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 3.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 1.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 2.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 1.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 1.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.5 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 1.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.5 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 2.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 1.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 1.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 3.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 3.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.6 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 1.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 2.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 2.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.7 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 1.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 1.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 1.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 1.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 2.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 1.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 1.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |